| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exec. Director, Finance - Pao
1 company
Jones Michael L serves as an Exec. Director, Finance - Pao at BCRX. Across recent SEC filings that breaks down to 0 buys and 3 sells.
Historically, Jones Michael L's trades have earned a strong insider score of 74/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +47.6%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2022 | BCRX Biocryst Pharmaceuticals Inc | Exec. Director, Finance - Pao | Sell | 445 | $10.90 | $4,850.50 | -4.0% | -22.6% | -42.7% | |
| Dec 1, 2022 | BCRX Biocryst Pharmaceuticals Inc | Exec. Director, Finance - Pao | Sale+OE | 8,600 | $13.01 | $111,886.00 | -43.4% | -31.9% | -52.5% | |
| Mar 1, 2022 | BCRX Biocryst Pharmaceuticals Inc | Exec. Director, Finance - Pao | Sale+OE | 2,300 | $17.20 | $39,560.00 | -17.0% | -44.6% | -47.5% |